This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Susan Y. Chu, PhD; Debra L. Hanson, MS; Carol Ciesielski, MD; John W. Ward, MD
for the Adolescent and Adult HIV Spectrum of Disease Project Group Centers for Disease Control and Prevention Atlanta, Ga

JAMA. 1995;273(11):848.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—Current recommendations for the prevention of first episodes of Pneumocystis carinii pneumonia (PCP) in human immunodeficiency virus (HIV)—infected adults and adolescents state that prophylaxis should begin when the CD4⁺ count falls below 0.200 x 10⁹/L (200/µL).¹ However, the risk of PCP in patients with CD4⁺ counts greater than 0.200 x 10⁹/L, although low, is not zero, and some experts on the US Public Health Service Task Force that made the current recommendations felt that prophylaxis could also be considered in patients with higher CD4⁺ counts.¹

We have estimated the number of cases of primary PCP that could potentially be prevented if the recommended CD4⁺ threshold for initiating prophylaxis were raised to 0.300 x 10⁹/L, using data from a large multisite project in which medical records of HIV-infected patients are reviewed at regular intervals.² Between January 1990 and April . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?